TAK1 介导的磷酸化对 RIPK1 激活的调控决定了细胞凋亡和坏死性凋亡。

Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.

作者信息

Geng Jiefei, Ito Yasushi, Shi Linyu, Amin Palak, Chu Jiachen, Ouchida Amanda Tomie, Mookhtiar Adnan Kasim, Zhao Heng, Xu Daichao, Shan Bing, Najafov Ayaz, Gao Guangping, Akira Shizuo, Yuan Junying

机构信息

Department of Cell Biology, Harvard Medical School, 240 Longwood Ave, Boston, MA, 02115, USA.

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, Shanghai, 201210, China.

出版信息

Nat Commun. 2017 Aug 25;8(1):359. doi: 10.1038/s41467-017-00406-w.

Abstract

Stimulation of TNFR1 by TNFα can promote three distinct alternative mechanisms of cell death: necroptosis, RIPK1-independent and -dependent apoptosis. How cells decide which way to die is unclear. Here, we report that TNFα-induced phosphorylation of RIPK1 in the intermediate domain by TAK1 plays a key role in regulating this critical decision. Using phospho-Ser321 as a marker, we show that the transient phosphorylation of RIPK1 intermediate domain induced by TNFα leads to RIPK1-independent apoptosis when NF-κB activation is inhibited by cycloheximide. On the other hand, blocking Ser321 phosphorylation promotes RIPK1 activation and its interaction with FADD to mediate RIPK1-dependent apoptosis (RDA). Finally, sustained phosphorylation of RIPK1 intermediate domain at multiple sites by TAK1 promotes its interaction with RIPK3 and necroptosis. Thus, absent, transient and sustained levels of TAK1-mediated RIPK1 phosphorylation may represent distinct states in TNF-RSC to dictate the activation of three alternative cell death mechanisms, RDA, RIPK1-independent apoptosis and necroptosis.TNFα can promote three distinct mechanisms of cell death: necroptosis, RIPK1-independent and dependent apoptosis. Here the authors show that TNFα-induced phosphorylation of RIPK1 in the intermediate domain by TAK1 plays a key role in regulating this decision.

摘要

肿瘤坏死因子α(TNFα)对肿瘤坏死因子受体1(TNFR1)的刺激可促进三种不同的细胞死亡替代机制:坏死性凋亡、不依赖于受体相互作用蛋白激酶1(RIPK1)和依赖于RIPK1的凋亡。细胞如何决定采用哪种死亡方式尚不清楚。在此,我们报告,转化生长因子β激活激酶1(TAK1)介导的TNFα诱导的RIPK1中间结构域磷酸化在调节这一关键决定中起关键作用。以磷酸化丝氨酸321为标志物,我们发现,当用放线菌酮抑制核因子κB(NF-κB)激活时,TNFα诱导的RIPK1中间结构域瞬时磷酸化会导致不依赖于RIPK1的凋亡。另一方面,阻断丝氨酸321磷酸化会促进RIPK1激活及其与Fas相关死亡结构域蛋白(FADD)的相互作用,从而介导依赖于RIPK1的凋亡(RDA)。最后,TAK1介导的RIPK1中间结构域在多个位点的持续磷酸化会促进其与RIPK3的相互作用以及坏死性凋亡。因此,TAK1介导的RIPK1磷酸化的缺失、瞬时和持续水平可能代表肿瘤坏死因子受体信号复合物(TNF-RSC)中的不同状态,以决定三种替代细胞死亡机制(RDA、不依赖于RIPK1的凋亡和坏死性凋亡)的激活。TNFα可促进三种不同的细胞死亡机制:坏死性凋亡、不依赖于RIPK1和依赖于RIPK1的凋亡。本文作者表明,TAK1介导的TNFα诱导的RIPK1中间结构域磷酸化在调节这一决定中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897a/5572456/d4c6a5472085/41467_2017_406_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索